Chugai Pharmaceutical Co., Ltd. (CHGCF)
OTCMKTS · Delayed Price · Currency is USD
56.23
-2.31 (-3.95%)
At close: Jan 28, 2026
Chugai Pharmaceutical Market Cap
Chugai Pharmaceutical has a market cap or net worth of $89.41 billion as of January 29, 2026. Its market cap has increased by 22.01% in one year.
Market Cap
89.41B
Enterprise Value
83.64B
Revenue
8.20B
Ranking
n/a
PE Ratio
33.31
Stock Price
$56.23
Market Cap Chart
Since January 6, 1992, Chugai Pharmaceutical's market cap has increased from 2.50B to 89.41B, an increase of 3,475.09%. That is a compound annual growth rate of 11.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 89.41B | 3.00% |
| Dec 30, 2025 | 86.81B | 18.46% |
| Dec 30, 2024 | 73.28B | 17.53% |
| Dec 29, 2023 | 62.35B | 48.41% |
| Dec 30, 2022 | 42.01B | -21.23% |
| Dec 30, 2021 | 53.34B | -39.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 834.76M |
| Glass House Brands | 764.02M |
| Elite Pharmaceuticals | 465.76M |
| Northwest Biotherapeutics | 458.23M |
| Nika Pharmaceuticals | 403.38M |
| American Oncology Network | 394.41M |
| Tian'an Technology Group | 318.63M |
| CytoDyn | 317.63M |